US Crack tooth syndrome Market

ID: MRFR/MED/18364-HCR 100 Pages Nidhi Mandole Last Updated: September 10, 2026
US Crack Tooth Syndrome Market Research Report By Diagnosis (Clinical Examination, Dye Test, X-ray, Transillumination, Radiograph, Others), By Treatment (Stabilization, Crown Restoration, Root Canal Therapy, Extraction, Others) and By Devices (Implants, Adhesives, Expendables, Others) - Growth & Industry Forecast 2025 To 2035
US Crack tooth syndrome Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.86%
2024 Market Size$ 306 Million
2025 Market Size$ 326.99 Million
2035 Market Size$ 635 Million
Key Players
Dentsply Sirona
Henry Schein
3M
Danaher Corporation
Coltene Holding AG
Ivoclar Vivadent AG
Trends
  • Rising Awareness of Dental Health
  • Advancements in Diagnostic Technologies
  • Demographic Shifts and Aging Population
Opportunities
  • Growing Demand for Aesthetic Dentistry
  • Increased Accessibility to Dental Care
  • Increasing Incidence of Dental Disorders
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Diagnosis (USD Million)
      1. 4.1.1 clinical examination
      2. 4.1.2 dye test
      3. 4.1.3 X-ray
      4. 4.1.4 transillumination
      5. 4.1.5 radiograph
      6. 4.1.6 others
    2. 4.2 Life Sciences, BY Types (USD Million)
      1. 4.2.1 completely fractured teeth
      2. 4.2.2 incompletely fractured teeth
    3. 4.3 Life Sciences, BY Drug Class (USD Million)
      1. 4.3.1 pain killers
      2. 4.3.2 anti-biotic
      3. 4.3.3 others
    4. 4.4 Life Sciences, BY Treatment (USD Million)
      1. 4.4.1 stabilization
      2. 4.4.2 crown restoration
      3. 4.4.3 root canal therapy
      4. 4.4.4 extraction
      5. 4.4.5 others
    5. 4.5 Life Sciences, BY Devices (USD Million)
      1. 4.5.1 implants
      2. 4.5.2 adhesives
      3. 4.5.3 expendables
      4. 4.5.4 others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Dentsply Sirona (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Henry Schein (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 3M (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Danaher Corporation (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Coltene Holding AG (CH)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Ivoclar Vivadent AG (LI)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Kerr Corporation (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 GC Corporation (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Voco GmbH (DE)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY DIAGNOSIS
    3. 6.3 US MARKET ANALYSIS BY TYPES
    4. 6.4 US MARKET ANALYSIS BY DRUG CLASS
    5. 6.5 US MARKET ANALYSIS BY TREATMENT
    6. 6.6 US MARKET ANALYSIS BY DEVICES
    7. 6.7 KEY BUYING CRITERIA OF LIFE SCIENCES
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF LIFE SCIENCES
    10. 6.10 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    12. 6.12 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    13. 6.13 LIFE SCIENCES, BY DIAGNOSIS, 2024 (% SHARE)
    14. 6.14 LIFE SCIENCES, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
    15. 6.15 LIFE SCIENCES, BY TYPES, 2024 (% SHARE)
    16. 6.16 LIFE SCIENCES, BY TYPES, 2024 TO 2035 (USD Million)
    17. 6.17 LIFE SCIENCES, BY DRUG CLASS, 2024 (% SHARE)
    18. 6.18 LIFE SCIENCES, BY DRUG CLASS, 2024 TO 2035 (USD Million)
    19. 6.19 LIFE SCIENCES, BY TREATMENT, 2024 (% SHARE)
    20. 6.20 LIFE SCIENCES, BY TREATMENT, 2024 TO 2035 (USD Million)
    21. 6.21 LIFE SCIENCES, BY DEVICES, 2024 (% SHARE)
    22. 6.22 LIFE SCIENCES, BY DEVICES, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DIAGNOSIS, 2025-2035 (USD Million)
      2. 7.2.2 BY TYPES, 2025-2035 (USD Million)
      3. 7.2.3 BY DRUG CLASS, 2025-2035 (USD Million)
      4. 7.2.4 BY TREATMENT, 2025-2035 (USD Million)
      5. 7.2.5 BY DEVICES, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Crack tooth syndrome Market Segmentation

US Crack tooth syndrome Market By Diagnosis (USD Million, 2025-2035)

  • clinical examination
  • dye test
  • X-ray
  • transillumination
  • radiograph
  • others

US Crack tooth syndrome Market By Types (USD Million, 2025-2035)

  • completely fractured teeth
  • incompletely fractured teeth

US Crack tooth syndrome Market By Drug Class (USD Million, 2025-2035)

  • pain killers
  • anti-biotic
  • others

US Crack tooth syndrome Market By Treatment (USD Million, 2025-2035)

  • stabilization
  • crown restoration
  • root canal therapy
  • extraction
  • others

US Crack tooth syndrome Market By Devices (USD Million, 2025-2035)

  • implants
  • adhesives
  • expendables
  • others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.